Found 7 matching trials
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study
PHASE1The objective of this study is to investigate the safety, tolerability, and...
Status
Active Not Recruiting
An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer
PHASE2This is an open-label Phase II modular study in participants with prostate ...
AZD4635 Relative Bioavailability Study
PHASE1To investigate the pharmacokinetics and relative bioavailability of AZD4635...
A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy Volunteers
PHASE1This study is a Phase I, open-label, non-randomized, 2-period, fixed-sequen...
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
PHASE1This is a Phase 1, open-label, multicenter study of continuous oral dosing ...
A Study of AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.
PHASE2This is a Phase II, international, open-label, two-arm, non-randomised stud...
A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies
PHASE1This is a Phase I, open-label study to assess the safety, tolerability, pha...